Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV Melanoma

NCT02659540 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
RADIATION: Radiotherapy

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]
[object Object]